Literature DB >> 24500811

Proteome of human plasma very low-density lipoprotein and low-density lipoprotein exhibits a link with coagulation and lipid metabolism.

M Dashty, M M Motazacker, J Levels, M de Vries, M Mahmoudi, M P Peppelenbosch, F Rezaee1.   

Abstract

Apart from transporting lipids through the body, the human plasma lipoproteins very low-density lipoprotein (VLDL) and low-density lipoprotein (LDL) are also thought to serve as a modality for intra-organismal protein transfer, shipping proteins with important roles in inflammation and thrombosis from the site of synthesis to effector locations. To better understand the role of VLDL and LDL in the transport of proteins, we applied a combination of LTQ ORBITRAP-XL (nLC-MS/MS) with both in-SDS-PAGE gel and in-solution tryptic digestion of pure and defined VLDL and LDL fractions. We identified the presence of 95 VLDL- and 51 LDL-associated proteins including all known apolipoproteins and lipid transport proteins, and intriguingly a set of coagulation proteins, complement system and anti- microbial proteins. Prothrombin, protein S, fibrinogen γ, PLTP, CETP, CD14 and LBP were present on VLDL but not on LDL. Prenylcysteine oxidase 1, dermcidin, cathelicidin antimicrobial peptide, TFPI-1 and fibrinogen α chain were associated with both VLDL and LDL. Apo A-V is only present on VLDL and not on LDL. Collectively, this study provides a wealth of knowledge on the protein constituents of the human plasma lipoprotein system and strongly supports the notion that protein shuttling through this system is involved in the regulation of biological processes. Human diseases related to proteins carried by VLDL and LDL can be divided in three major categories: 1 - dyslipidaemia, 2 - atherosclerosis and vascular disease, and 3 - coagulation disorders.

Entities:  

Keywords:  CD14; CETP; LCAT; PLTP; Proteomics; TFPI-1; anti-microbial peptides; apoAV; apolipoproteins; atherothrombosis; cathepcin D; coagulation; dermicidin; lipopolysaccharide binding protein; lysozyme C; nLC-MS/MS; prenylcysteine oxidase; protein S; prothrombin

Mesh:

Substances:

Year:  2014        PMID: 24500811     DOI: 10.1160/TH13-02-0178

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  37 in total

1.  A comparison of the mouse and human lipoproteome: suitability of the mouse model for studies of human lipoproteins.

Authors:  Scott M Gordon; Hailong Li; Xiaoting Zhu; Amy S Shah; L Jason Lu; W Sean Davidson
Journal:  J Proteome Res       Date:  2015-04-27       Impact factor: 4.466

2.  A Comparison of Methods To Enhance Protein Detection of Lipoproteins by Mass Spectrometry.

Authors:  Anna Heink; W Sean Davidson; Debi K Swertfeger; L Jason Lu; Amy S Shah
Journal:  J Proteome Res       Date:  2015-06-12       Impact factor: 4.466

3.  Association of rheumatoid arthritis disease activity and antibodies to periodontal bacteria with serum lipoprotein profile in drug naive patients.

Authors:  Aulikki Kononoff; Pia Elfving; Pirkko Pussinen; Sohvi Hörkkö; Hannu Kautiainen; Leena Arstila; Leena Laasonen; Elina Savolainen; Helena Niinisalo; Jarno Rutanen; Olga Marjoniemi; Mari Hämäläinen; Katriina Vuolteenaho; Eeva Moilanen; Oili Kaipiainen-Seppänen
Journal:  Ann Med       Date:  2020-02-10       Impact factor: 4.709

4.  Mapping Atheroprotective Functions and Related Proteins/Lipoproteins in Size Fractionated Human Plasma.

Authors:  Debi K Swertfeger; Hailong Li; Sandra Rebholz; Xiaoting Zhu; Amy S Shah; W Sean Davidson; Long J Lu
Journal:  Mol Cell Proteomics       Date:  2017-02-21       Impact factor: 5.911

5.  Metabolism and proteomics of large and small dense LDL in combined hyperlipidemia: effects of rosuvastatin.

Authors:  Nuntakorn Thongtang; Margaret R Diffenderfer; Esther M M Ooi; P Hugh R Barrett; Scott M Turner; Ngoc-Anh Le; W Virgil Brown; Ernst J Schaefer
Journal:  J Lipid Res       Date:  2017-04-09       Impact factor: 5.922

6.  Heparin binding triggers human VLDL remodeling by circulating lipoprotein lipase: Relevance to VLDL functionality in health and disease.

Authors:  Shobini Jayaraman; Antonio Pérez; Inka Miñambres; Jose Luis Sánchez-Quesada; Olga Gursky
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2021-10-02       Impact factor: 4.698

7.  An Unbiased Mass Spectrometry Approach Identifies Glypican-3 as an Interactor of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) and Low Density Lipoprotein Receptor (LDLR) in Hepatocellular Carcinoma Cells.

Authors:  Kévin Ly; Rachid Essalmani; Roxane Desjardins; Nabil G Seidah; Robert Day
Journal:  J Biol Chem       Date:  2016-10-07       Impact factor: 5.157

8.  Inhibition of the aryl hydrocarbon receptor prevents Western diet-induced obesity. Model for AHR activation by kynurenine via oxidized-LDL, TLR2/4, TGFβ, and IDO1.

Authors:  Benjamin J Moyer; Itzel Y Rojas; Joanna S Kerley-Hamilton; Haley F Hazlett; Krishnamurthy V Nemani; Heidi W Trask; Rachel J West; Leslie E Lupien; Alan J Collins; Carol S Ringelberg; Barjor Gimi; William B Kinlaw; Craig R Tomlinson
Journal:  Toxicol Appl Pharmacol       Date:  2016-03-25       Impact factor: 4.219

9.  Regulation of Macrophage Recognition through the Interplay of Nanoparticle Surface Functionality and Protein Corona.

Authors:  Krishnendu Saha; Mehran Rahimi; Mahdieh Yazdani; Sung Tae Kim; Daniel F Moyano; Singyuk Hou; Ridhha Das; Rubul Mout; Farhad Rezaee; Morteza Mahmoudi; Vincent M Rotello
Journal:  ACS Nano       Date:  2016-04-11       Impact factor: 15.881

10.  Robust sequential biophysical fractionation of blood plasma to study variations in the biomolecular landscape of systemically circulating extracellular vesicles across clinical conditions.

Authors:  Glenn Vergauwen; Joeri Tulkens; Cláudio Pinheiro; Francisco Avila Cobos; Sándor Dedeyne; Marie-Angélique De Scheerder; Linos Vandekerckhove; Francis Impens; Ilkka Miinalainen; Geert Braems; Kris Gevaert; Pieter Mestdagh; Jo Vandesompele; Hannelore Denys; Olivier De Wever; An Hendrix
Journal:  J Extracell Vesicles       Date:  2021-08-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.